title: New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.
abstract: The epidermal growth factor receptor (EGFR) is a validated target in squamous cell carcinoma of the head and neck (HNSCC). However, despite high expression of EGFR in these cancers, EGFR inhibitor monotherapy has only had modest activity. Potential mechanisms of resistance to EGFR-targeted therapies involve EGFR and Ras mutations, epithelial-mesenchymal transition, and activation of alternative and downstream pathways. Strategies to optimize EGFR-targeted therapy in head and neck cancer involve not only the selection for patients most likely to benefit but also the use of combination therapies to target the network of pathways involved in tumor growth, invasion, angiogenesis, and metastasis.
authors.affiliation: University of Chicago, Chicago, Illinois 60637, USA.
authors.forename: Lucy F
authors.initials: LF
authors.lastname: Chen
authors.forename: Ezra E W
authors.initials: EE
authors.lastname: Cohen
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Grandis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects* / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans; D008954:Models, Biological; D009154:Mutation
chemical_list: D066246:ErbB Receptors
references.citation: Ann Oncol. 2008 Apr;19(4):717-23
references.pmid: 17974556
references.citation: Cancer Res. 2005 Oct 15;65(20):9455-62
references.pmid: 16230409
references.citation: J Clin Oncol. 2004 Jan 1;22(1):77-85
references.pmid: 14701768
references.citation: J Clin Invest. 2008 Jul;118(7):2609-19
references.pmid: 18568074
references.citation: Cancer Res. 2008 May 1;68(9):3314-22
references.pmid: 18451158
references.citation: J Clin Oncol. 2013 Apr 10;31(11):1405-14
references.pmid: 23460714
references.citation: Cancer Res. 2009 Apr 15;69(8):3256-61
references.pmid: 19351834
references.citation: Cancer Res. 2007 Oct 1;67(19):9304-14
references.pmid: 17909038
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1235-42
references.pmid: 19204206
references.citation: Curr Protoc Hum Genet. 2008 Apr;Chapter 10:Unit 10.11
references.pmid: 18428421
references.citation: Clin Cancer Res. 2006 Jul 1;12(13):4103-11
references.pmid: 16818711
references.citation: Cell Growth Differ. 2002 Aug;13(8):355-62
references.pmid: 12193474
references.citation: Mol Cancer Ther. 2008 Nov;7(11):3499-508
references.pmid: 18974395
references.citation: J Clin Oncol. 2005 Dec 1;23(34):8646-54
references.pmid: 16314626
references.citation: Oral Oncol. 2009 Oct;45(10):e161-6
references.pmid: 19628422
references.citation: Science. 2007 Oct 12;318(5848):287-90
references.pmid: 17872411
references.citation: Int J Cancer. 2007 Apr 15;120(8):1731-8
references.pmid: 17236202
references.citation: Innate Immun. 2009 Apr;15(2):91-100
references.pmid: 19318419
references.citation: Methods Mol Biol. 2009;542:335-49
references.pmid: 19565911
references.citation: J Biol Chem. 2003 Aug 22;278(34):31574-83
references.pmid: 12771142
references.citation: Cancer Res. 2009 Mar 1;69(5):1851-7
references.pmid: 19223544
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7764-74
references.pmid: 15570011
references.citation: J Clin Oncol. 2008 Mar 1;26(7):1119-27
references.pmid: 18309947
references.citation: Cancer Res. 2001 Jul 1;61(13):5090-101
references.pmid: 11431346
references.citation: Cancer Res. 2005 Jun 15;65(12):5076-83
references.pmid: 15958551
references.citation: Cancer Immunol Immunother. 2009 Nov;58(11):1853-64
references.pmid: 19319529
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4138-43
references.pmid: 12640143
references.citation: J Clin Oncol. 2005 Sep 1;23(25):5900-9
references.pmid: 16043828
references.citation: Clin Cancer Res. 2005 Nov 15;11(22):8105-8
references.pmid: 16299242
references.citation: Biochem Pharmacol. 2008 Mar 1;75(5):1035-44
references.pmid: 18191814
references.citation: Clin Cancer Res. 2009 Jan 15;15(2):532-42
references.pmid: 19147758
references.citation: J Pharmacol Exp Ther. 1999 Nov;291(2):739-48
references.pmid: 10525095
references.citation: Eur J Cancer. 2003 Jul;39(10):1348-54
references.pmid: 12826036
references.citation: Cancer Res. 2006 Apr 15;66(8):3992-5
references.pmid: 16618717
references.citation: Cancer Res. 2008 Oct 15;68(20):8322-32
references.pmid: 18922904
references.citation: J Clin Oncol. 2009 Mar 1;27(7):1100-7
references.pmid: 19171712
references.citation: N Engl J Med. 2008 Sep 11;359(11):1116-27
references.pmid: 18784101
references.citation: Cancer Res. 2005 Jan 1;65(1):46-53
references.pmid: 15665278
references.citation: J Clin Oncol. 2000 Nov 1;18(21 Suppl):47S-53S
references.pmid: 11060327
references.citation: J Natl Cancer Inst. 2007 Jun 6;99(11):838-46
references.pmid: 17551144
references.citation: Br J Cancer. 2007 Mar 26;96(6):952-9
references.pmid: 17342092
references.citation: Oncogene. 2008 May 1;27(20):2934-40
references.pmid: 18059341
references.citation: J Clin Oncol. 2008 Jul 1;26(19):3128-37
references.pmid: 18474878
references.citation: J Clin Oncol. 2008 Jul 10;26(20):3351-7
references.pmid: 18612151
references.citation: Int J Oncol. 1998 Nov;13(5):971-4
references.pmid: 9772288
references.citation: Br J Cancer. 2007 Apr 23;96(8):1166-9
references.pmid: 17375050
references.citation: J Clin Oncol. 2006 Jun 20;24(18):2866-72
references.pmid: 16717293
references.citation: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10217-21
references.pmid: 7937865
references.citation: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8686-98
references.pmid: 16361555
references.citation: Cancer Res. 2003 Jun 1;63(11):2948-56
references.pmid: 12782602
references.citation: Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):755-60
references.pmid: 7912510
references.citation: Cancer Res. 2004 Dec 15;64(24):9139-43
references.pmid: 15604284
references.citation: J Clin Oncol. 2007 Feb 10;25(5):587-95
references.pmid: 17290067
references.citation: J Clin Oncol. 2003 May 15;21(10):1980-7
references.pmid: 12743152
references.citation: Clin Cancer Res. 2006 Sep 1;12(17):5064-73
references.pmid: 16951222
references.citation: N Engl J Med. 2006 Feb 9;354(6):567-78
references.pmid: 16467544
references.citation: Br J Cancer. 2008 Jan 15;98(1):80-5
references.pmid: 18026190
references.citation: Semin Oncol. 2008 Jun;35(3):274-85
references.pmid: 18544442